The growth of myelodysplastic bone marrow in long-term cultures. by Borbenyi, Z. et al.
Br. J. Cancer (1987), 55, 291-293 © The Macmillan Press Ltd., 1987
SHORT COMMUNICATION
The growth of myelodysplastic bone marrow in long-term cultures
Z. Borbenyil*, C. Cinkotai2, C. Harrison' & N.G. Testa'
IPaterson Institutefor Cancer Research, Christie Hospital and Holt Radium Institute, Wilmslow Road, Withington, Manchester,
M20 9BX and 2Department ofHaematology, Manchester Royal Infirmary, Manchester, M13 9WL, UK.
The myelodysplastic syndromes (MDS) are characterised by
the presence of one or several cytopaenias in the peripheral
blood and by maturation abnormalities in the bone marrow
(reviewed by Jacobs, 1985; 1987). Even in the absence of
leukaemic transformation, MDS are lethal haematological
disorders (Weisdorf et al., 1983) with high mortality from
infection and bleeding due not only to the cytopaenias but
also to defective function of the neutrophils (Boogaerts et
al., 1983) and platelets (Russel et al., 1979). Although the
development of an acute leukaemia is not obligatory and the
time of appearance varies considerably (Coiffier et al., 1985,
Greenberg, 1983), MDS is the only human model of
leukaemogenesis that can be investigated in detail.
Long-term bone marrow cultures (LTC) allow the study of
cell proliferation and differentiation, and of the interactions
between stromal and haemopoietic cells (Dexter et al., 1984).
In this work LTC cultures from patients with MDS were
performed to evaluate their growth and differentiation
patterns.
The diagnosis of MDS was based on FAB diagnostic
criteria (Bennett et al., 1982). The group studied included 3
patients with refractory anaemia (RA) 2 patients with
sideroblastic anaemia (PASA), 9 patients with refractory
anaemia with excess of blasts (RAEB) and one patient with
refractory anaemia with excess of blasts in transformation
(RAEB-T). Aspiration bone marrow samples were obtained
from the iliac crest. Control samples were obtained after
informed consent from 9 haematologically normal patients
undergoing surgery.
Long-term bone marrow cultures were established by
seeding 2 x 107 nucleated cells into 25cm2 tissue culture
flasks containing 10ml Iscove's medium supplemented with
10% preselected foetal calf serum (FCS, Flow Labs) 10%
preselected horse serum, (Gibco) antibodies and 5 x 107 M
hydrocortisone hemisuccinate. The cultures were incubated
at 33°C in a gas phase of 5% CO2 in air. At weekly intervals
half of the medium together with the non-adherent cells were
removed and replaced with an equal volume of fresh
medium (Coutinho et al., 1986). The number of nucleated
cells and of progenitors of granulocytes and macrophages
(GM-CFC) in the harvested medium were determined.
Adherent layers developed fully after 2-3 weeks of culture.
In some cultures the adherent cells were removed by
trypsinisation (Coulumbel et al., 1983) and assayed for
haemopoietic progenitor cells as described below. The cell
morphology of the harvested cells was assessed in
cytocentrifuge preparations stained with Wright's Giemsa.
For the GM-CFC assay bone marrow cells were plated at
I x I0 ml-I in a final concentration of 0.3% agar (Testa,
1985) in Iscove's medium containing 15% (vol:vol) FCS and
20% (vol:vol) supernatant of the bladder carcinoma cell line
5637 as the source of colony stimulating factor (CSF)
(Myers et al., 1984) and incubated at 37°C in a fully
humidified atmosphere of 5% CO2 in air. The colonies were
scored at day 11. Clones of more than 50 cells were counted
as colonies.
The number of GM-CFC in the bone marrow freshly
harvested from patients with MDS was significantly low
compared to normal controls 15.1 +4.03 versus 54.7+ 14.7
per 105 bone marrow cells. The mean incidence of colonies
was similar in the PASA and RA patients than in the cases
of RAEB (19 and 13 respectively). However, some of the
latter showed increased numbers of clusters (data not
shown). The decreased incidence of GM-CFC and the
increased number of clusters found here agree with previous
results (Greenberg et al., 1971; Senn & Pinkerton, 1972;
Milner et al., 1977; Spitzer et al., 1979). Some studies have
suggested that colony incidence decreases as the disease
progressess, so low colony formation might be expected to
indicate impending transformation. However, we found a
similar incidence of colonies (although in some cases
increased clusters) in the RAEB patients (including one case
in transformation) and in patients with RA or PASA. This is
in agreement with some reports (Milner et al., 1977; Francis
et al., 1983).
In LTC both the cellularity and the number of GM-CFC
in the non-adherent fraction were reduced in patients in
comparison to controls. The defect was much more marked
in the GM-CFC (Figure 1): in the first 4 weeks of culture,
the numbers of nucleated cells were 3 to 9 x and the
numbers of GM-CFC were 17 to 109 x lower than in
control cultures. As there were no consistent differences
among the MDS subgroups, Figure 1 shows pooled data.
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Figure 1 Numbers of nucleated cells (a) and of GM-CFC; (b) in
the supernatant of long term bone marrow cultures from patients
with MDS (0) and controls (0).
After the third week, when the adherent layer is usually
fully developed in normal cultures, the cellularity of-the
adherent layer and its GM-CFC content were examined:
both reduced cellularity and low GM-CFC content were
observed in MDS (Figure 2).
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The cellular composition of the non-adherent layer in LTC
is shown in Table I. There was a higher proportion of blast
cells and a lower proportion of metamyelocytes and mature
granulocytes in LTC from patients with MDS than from
controls at week 1. However, they decreased by week 4, and
this was accompanied by an increase in the proportion of
mature granulocytes and macrophages (Table I), although
overall they remained lower than in the controls.
Interestingly, the changes were of similar magnitude in the
cultures from RA to PASA, than in the RAEB and RAEB-T
patients. In the adherent layer the great majority of cells
were fibroblastic (reticular), adypocytes and macrophages,
both in control and MDS cultures. No qualitative changes in
the morphology of the adherent cells were observed;
however, on direct examination the development of the
stromal layer. was patchy and, unlike control cultures, never
reached confluence.
The decreased numbers of nucleated cells, and the even
lower numbers of GM-CFC in the LTC of MDS patients
may result not only from the abnormality of the MDS clone,
but also from abnormalities in the haemopoietic
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Figure 2 Numbers of nucleated cells (a) and of GM-CFC; (b) in
the adherent layer of long-term bone marrow cultures from
patients with MDS (-) and controls (0).
environment. This is supported by the lower numbers and
limited growth of the stromal cells observed in the adherent
layer. Although no gross changes in the stromal cell types
were observed here, these studies are only of a preliminary
nature: phenotypic characterisation, production of growth
and differentiation factors, as well as detailed quantitative
studies are necessary to characterise the stromal cells in this
syndrome. It is not known, however, whether the changes
observed in the stromal cells are early changes which may
have a bearing in the development of MDS, or are
secondary phenomena.
The cell maturation in LTC appears to follow a similar
pattern in MDS and in the control cultures in that the
proportion of blasts decreases, while that of the mature
granulocyte and monocyte-macrophages increases, in the
case of the latter to control levels. This may indicate that in
LTC, the MDS cells are able to respond to maturation
signals in the environment. Alternatively, the mature cells
may represent the emergence of residual normal
haemopoiesis. Chromosome or molecular markers are
necessary to distinguish between these two possibilities,
which are not mutually exclusive. Such studies are in
progress.
It is of interest that neither the original incidence of
colonies in the bone marrow, nor their incidence in long-
term cultures, nor the differentiation pattern, show
differences between the patients with RA or PASA and those
with RAEB in this admittedly small sample. In this context
it is surprising that in those patients for whom cytogenetic
data are available, 4 patients with cytogenetic abnormalities
(-Y; -5; and -7 in two cases) showed similar incidence of
GM-CFC (16+3.0 per 105 cells) compared to 7 patients with
a normal karyotype (12+3.8). Also, their growth pattern in
LTC was similar. While this restricts the usefulness of the
LTC and colony assays as predictive tests of evolution, these
studies may also indicate that even RA and PASA are quite
advanced along the path towards leukaemia. These studies,
however, provide the baseline data of a model in which
corrective therapy may be studied: for example the use of
growth and differentiation factors which may control or
extinguish the pre-leukaemic clones, and stimulate the re-
emergence of normal haemopoiesis.
This work was supported by the Cancer Research Campaign, Great
Britain.
Table I Morphology of non-adherent cells from long-term cultures
% Band % Lymphocytes % Blasts and % Myelocytes and andsegmented % Monocytes andnucleated Week Cultures promyelocytes metamyelocytes granulocytes and macrophages erythroid cells
1 Controls 2+0.81 26.22+3.9 40.77+2.77 7.66+2.99 21.44+2.67 RA+PASA 9.0 +9.89 21.2 +2.93 24.4 +6.28 21.2 +5.15 26.2 +8.28 RAEB+RAEB-T 12.7 +1.41 18.2 +5.28 23.3 +3.55 21.6 +5.10 23.2 +6.23 Controls 0.77+9.77 15.88 +3.17 49.22+3.32 30.44+4.00 4.22+2.14 4 RA+PASA 3.8 +9.75 15.8 +3.82 32.4 +2.65 33.8 +4.66 14.2 +3.82 RAEB+RAEB-T 4.7 + 1.75 17.8 +5.76 32.6 +3.2 37.4 +3.90 8.1 +2.21
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